A new vision for age-related macular degeneration

European Journal of Human Genetics

Volumn 13, Issue 7, 2005, Pages 793-794

  Gorin, Michael B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN; COMPLEMENT FACTOR H; HISTAMINE; TYROSINE; ZINC;

AGED; ALLELE; BLINDNESS; CASE CONTROL STUDY; CHROMOSOME ANALYSIS; EARLY DIAGNOSIS; ELDERLY CARE; FAMILY HISTORY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLOMERULONEPHRITIS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; NOTE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; VISION; WELLBEING;

AGE FACTORS; ANIMALS; COMPLEMENT FACTOR H; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); MACULAR DEGENERATION;

EID: 21744440270     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201431     Document Type: Note

References (23)

1. Haines JL, Hauser MA, Schmidt S et al: Complement factor H varient increases the risk of age-related macular degeneration. Science 2005, [E-pub ahead of print].
2. Edwards AO, Ritter III R, Abel KJ, Manning A, Panhuysen C, Farrer LA: Complement factor H polymorphism and age-related macular degeneration. Science 2005, [E-pub ahead of print].
3. Klein RJ, Zeiss C, Chew EY et al: Complement factor H polymorphism in age-related macular degeneration. Science 2005, [E-pub ahead of print].
4. Group TEDPR: Prevalence of Age-Related Macular Degeneration in the United States. Arch Ophthalmol 2004; 122: 564-572.
5. Weeks DE, Conley YP, Mah TS et al: A full genome scan for age-related maculopathy. Hum Mol Genet 2000; 9: 1329-1349.
6. Weeks D, Conley Y, Tsai H-J et al: Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. Am J Ophthalmol 2001; 135: 682-692.
7. Majewski J, Schultz DW, Weleber RG et al: Age-related macular degeneration - a genome scan in extended families. Am J Hum Genet 2003; 73: 540-550.
8. Schick JH, Iyengar SK, Klein BE et al: A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study. Am J Hum Genet 2003; 72: 1412-1424.
9. Seddon JM, Santangelo SL, Book K, Chong S, Cote J: A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet 2003; 73: 780-790.
10. Abecasis GR, Yashar BM, Zhao Y et al: Age-related macular degeneration: a high-resolution genome scan for susceplibility loci in a population enriched foi late-stage disease. Am J Hum Genet 2004; 74: 482-494.
11. Page GP, George V, Go RC, Page PZ, Allison DB: Are we there yet? Deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits. Am J Hum Genet 2003; 73: 711-719.
12. Hill A: The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295-300.
13. Mullins RF, Johnson TV, Anderson DH, Hageman GS: Characterization of drusen-associated glycoconjugates. Ophthalmology 1997; 104: 288-294.
14. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF: An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Progr Retin Eye Res 2001; 20: 705-732.
15. Johnson LV, Leitner WP, Staples MK, Anderson DH: Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp Eye Res 2001; 73: 887-896.
16. Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DH: A potential role for immune complex pathogenesis in Drusen formation. Exp Eye Res 2000; 70: 441-449.
17. Levy M, Halbwachs-Mecarelli L, Gubler MC et al: H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int 1986; 30: 949-956.
18. Pickering MC, Cook HT, Warren J et al: Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H Nat Genet 2002; 31: 424-428.
19. Hogasen K, Jansen JH, Mollnes TE, Hovdenes J, Harboe M: Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency J Clin Invest 1995; 95: 1054-1061.
20. Leys A, Vanrenterghem Y, Van DB, Snyen B, Pirson Y, Leys M: Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients. Graefes Arch Clin Exp Ophthalmol 1991; 229: 406-410.
21. Mullins RF, Aptsiauri N, Hageman GS Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye 2001 15: 390-395.
22. Schmidt S, Klaver C, Saunders A et al A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet 2002; 23: 209-223.
23. Stone EM, Sheffield VC, Hageman GS Molecular genetics of age-related macular degeneration. Hum Mol Genet 2001; 10: 2285-2292.